DEERFIELD, Ill. Ginger Graham, president and CEO of Two Trees Consulting, will become Walgreens' 10th board member and serve as an independent director, effective May 1.
Graham has more than 20 years of experience in health care, including pharmaceuticals, medical devices and biotechnology. Prior to founding Two Trees Consulting in 2008, Graham was president and CEO of biopharmaceutical company Amylin, which mainly focuses on treatments for diabetes and obesity. Graham also serves on the boards of directors for Genomic Health, Proteus Biomedical Pharmaceutical Systems Division, ICAT Managers and the American Diabetes Association Research Foundation where she serves as vice chair.
“We value the experience and insight from Ginger’s career-long focus in developing strategies to bring innovative healthcare solutions to the market,” said Walgreens chairman Alan McNally. “We look forward to the contributions she will make as the company plays an even larger role in meeting the nation’s need for greater access to quality, affordable health care.”